Financial risk and hospital cost in stratified, peripheral vascular surgical DRGs without complications and comorbidities

Eric Munoz, Jon R. Cohen, Jonathan Goldstein, Teresa Benacquista, Katherine Mulloy, Leslie Wise

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The purpose of this study was to analyze hospital resource consumption in any of the nine non-complicating conditions covered under stratified, peripheral vascular surgical Diagnosis-Related Groups (DRGs) using the new DRG prospective AII Payer System in effect in New York. There is significant health policy debate at the level of the United States Congress regarding the improvement of the equity of DRG hospital payment. Although there have been a number of recommendations by federal advisory bodies to further stratify DRGs by complications and comorbidities, no major revision of DRGs along these lines has been implemented. The all payer system uses the DRG format to pay for all patients. We analyzed 788 peripheral vascular surgical patients by payer (Medicare, Medicaid, Blue Cross and commercial insurance) in these stratified, peripheral vascular surgical DRGs with no complica-tions or comorbidities for a three year period. Our study demonstrated that patients within each DRG with more complications and comorbidities generated higher total hospital costs, a longer hospital length of stay, a greater percentage of procedures per patient, financial risk under DRG payment, more outliers, and a higher mortality, compared to patients in these same DRGs with fewer complications and comorbidi-ties. These findings suggest that new, prospective DRG all payer systems may be inequitable to certain groups of patients or types of hospitals in these stratified peripheral vascular surgical DRGs with no complications or comorbidities. This analysis suggests that these peripheral vascular surgical DRGs should be stratified by the numbers and types of complications and comorbidities to more equitably reimburse hospitals under DRGs. Since all payer systems use the federal model, the inequities demonstrated in our study will be applicable to all peripheral vascular patients.

Original languageEnglish (US)
Pages (from-to)170-176
Number of pages7
JournalAnnals of Vascular Surgery
Volume3
Issue number2
DOIs
StatePublished - 1989

Fingerprint

Hospital Costs
Diagnosis-Related Groups
Blood Vessels
Comorbidity
Length of Stay
Blue Cross Blue Shield Insurance Plans
Medicaid
Medicare
Health Policy
Insurance

Keywords

  • All payer DRG systems
  • complications and comorbidities
  • costs
  • DRGs
  • peripheral vascular surgical DRGs

ASJC Scopus subject areas

  • Surgery
  • Cardiology and Cardiovascular Medicine

Cite this

Financial risk and hospital cost in stratified, peripheral vascular surgical DRGs without complications and comorbidities. / Munoz, Eric; Cohen, Jon R.; Goldstein, Jonathan; Benacquista, Teresa; Mulloy, Katherine; Wise, Leslie.

In: Annals of Vascular Surgery, Vol. 3, No. 2, 1989, p. 170-176.

Research output: Contribution to journalArticle

Munoz, Eric ; Cohen, Jon R. ; Goldstein, Jonathan ; Benacquista, Teresa ; Mulloy, Katherine ; Wise, Leslie. / Financial risk and hospital cost in stratified, peripheral vascular surgical DRGs without complications and comorbidities. In: Annals of Vascular Surgery. 1989 ; Vol. 3, No. 2. pp. 170-176.
@article{3171d8ff455e4cd18568e210c0057c4d,
title = "Financial risk and hospital cost in stratified, peripheral vascular surgical DRGs without complications and comorbidities",
abstract = "The purpose of this study was to analyze hospital resource consumption in any of the nine non-complicating conditions covered under stratified, peripheral vascular surgical Diagnosis-Related Groups (DRGs) using the new DRG prospective AII Payer System in effect in New York. There is significant health policy debate at the level of the United States Congress regarding the improvement of the equity of DRG hospital payment. Although there have been a number of recommendations by federal advisory bodies to further stratify DRGs by complications and comorbidities, no major revision of DRGs along these lines has been implemented. The all payer system uses the DRG format to pay for all patients. We analyzed 788 peripheral vascular surgical patients by payer (Medicare, Medicaid, Blue Cross and commercial insurance) in these stratified, peripheral vascular surgical DRGs with no complica-tions or comorbidities for a three year period. Our study demonstrated that patients within each DRG with more complications and comorbidities generated higher total hospital costs, a longer hospital length of stay, a greater percentage of procedures per patient, financial risk under DRG payment, more outliers, and a higher mortality, compared to patients in these same DRGs with fewer complications and comorbidi-ties. These findings suggest that new, prospective DRG all payer systems may be inequitable to certain groups of patients or types of hospitals in these stratified peripheral vascular surgical DRGs with no complications or comorbidities. This analysis suggests that these peripheral vascular surgical DRGs should be stratified by the numbers and types of complications and comorbidities to more equitably reimburse hospitals under DRGs. Since all payer systems use the federal model, the inequities demonstrated in our study will be applicable to all peripheral vascular patients.",
keywords = "All payer DRG systems, complications and comorbidities, costs, DRGs, peripheral vascular surgical DRGs",
author = "Eric Munoz and Cohen, {Jon R.} and Jonathan Goldstein and Teresa Benacquista and Katherine Mulloy and Leslie Wise",
year = "1989",
doi = "10.1007/BF03187387",
language = "English (US)",
volume = "3",
pages = "170--176",
journal = "Annals of Vascular Surgery",
issn = "0890-5096",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Financial risk and hospital cost in stratified, peripheral vascular surgical DRGs without complications and comorbidities

AU - Munoz, Eric

AU - Cohen, Jon R.

AU - Goldstein, Jonathan

AU - Benacquista, Teresa

AU - Mulloy, Katherine

AU - Wise, Leslie

PY - 1989

Y1 - 1989

N2 - The purpose of this study was to analyze hospital resource consumption in any of the nine non-complicating conditions covered under stratified, peripheral vascular surgical Diagnosis-Related Groups (DRGs) using the new DRG prospective AII Payer System in effect in New York. There is significant health policy debate at the level of the United States Congress regarding the improvement of the equity of DRG hospital payment. Although there have been a number of recommendations by federal advisory bodies to further stratify DRGs by complications and comorbidities, no major revision of DRGs along these lines has been implemented. The all payer system uses the DRG format to pay for all patients. We analyzed 788 peripheral vascular surgical patients by payer (Medicare, Medicaid, Blue Cross and commercial insurance) in these stratified, peripheral vascular surgical DRGs with no complica-tions or comorbidities for a three year period. Our study demonstrated that patients within each DRG with more complications and comorbidities generated higher total hospital costs, a longer hospital length of stay, a greater percentage of procedures per patient, financial risk under DRG payment, more outliers, and a higher mortality, compared to patients in these same DRGs with fewer complications and comorbidi-ties. These findings suggest that new, prospective DRG all payer systems may be inequitable to certain groups of patients or types of hospitals in these stratified peripheral vascular surgical DRGs with no complications or comorbidities. This analysis suggests that these peripheral vascular surgical DRGs should be stratified by the numbers and types of complications and comorbidities to more equitably reimburse hospitals under DRGs. Since all payer systems use the federal model, the inequities demonstrated in our study will be applicable to all peripheral vascular patients.

AB - The purpose of this study was to analyze hospital resource consumption in any of the nine non-complicating conditions covered under stratified, peripheral vascular surgical Diagnosis-Related Groups (DRGs) using the new DRG prospective AII Payer System in effect in New York. There is significant health policy debate at the level of the United States Congress regarding the improvement of the equity of DRG hospital payment. Although there have been a number of recommendations by federal advisory bodies to further stratify DRGs by complications and comorbidities, no major revision of DRGs along these lines has been implemented. The all payer system uses the DRG format to pay for all patients. We analyzed 788 peripheral vascular surgical patients by payer (Medicare, Medicaid, Blue Cross and commercial insurance) in these stratified, peripheral vascular surgical DRGs with no complica-tions or comorbidities for a three year period. Our study demonstrated that patients within each DRG with more complications and comorbidities generated higher total hospital costs, a longer hospital length of stay, a greater percentage of procedures per patient, financial risk under DRG payment, more outliers, and a higher mortality, compared to patients in these same DRGs with fewer complications and comorbidi-ties. These findings suggest that new, prospective DRG all payer systems may be inequitable to certain groups of patients or types of hospitals in these stratified peripheral vascular surgical DRGs with no complications or comorbidities. This analysis suggests that these peripheral vascular surgical DRGs should be stratified by the numbers and types of complications and comorbidities to more equitably reimburse hospitals under DRGs. Since all payer systems use the federal model, the inequities demonstrated in our study will be applicable to all peripheral vascular patients.

KW - All payer DRG systems

KW - complications and comorbidities

KW - costs

KW - DRGs

KW - peripheral vascular surgical DRGs

UR - http://www.scopus.com/inward/record.url?scp=85030131872&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030131872&partnerID=8YFLogxK

U2 - 10.1007/BF03187387

DO - 10.1007/BF03187387

M3 - Article

VL - 3

SP - 170

EP - 176

JO - Annals of Vascular Surgery

JF - Annals of Vascular Surgery

SN - 0890-5096

IS - 2

ER -